Indrayani Biotech Ltd Fair Value
INDRANIB · FMCG · Current price ₹8.2
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹12 | -6% ROE fading to 14% over ~3 yrs, on ₹16 book |
| Relative P/E | ₹29 | EPS × 21.0 peer-median P/E |
| Graham floor | ₹22 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Indrayani Biotech Ltd undervalued?
DocStoX estimates the fair value of Indrayani Biotech Ltd at ₹18 per share, versus the current market price of ₹8. That puts the stock about +123.7% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹12), Relative P/E (₹29), Graham floor (₹22). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹12 (bear) to ₹18 (base) to ₹29 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Indrayani Biotech Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.